先天性低促性腺激素性性腺功能减退症的可逆性
本文系统综述了男性先天性低促性腺激素性性腺功能减退症(CHH)逆转现象。约10%的男性CHH患者在停止激素治疗后出现下丘脑-垂体-性腺轴持续激活和/或生育力。逆转不同于青春期延迟,嗅觉表型不预测轴恢复,GNRHR变异促进逆转而ANOS1变异几乎排除恢复。
要点
- 约10%男性CHH患者停激素治疗后出现逆转。
- GNRHR变异促进逆转,ANOS1变异几乎排除恢复。
- 嗅觉表型不预测HPG轴恢复,需遗传检测辅助识别。
核心结论
- 男性CHH逆转现象扩展了对人类生殖调控的理解,但精确机制尚未阐明。
- 临床可利用体征和基因检测识别可能受益于密切监测逆转的患者。
研究设计与样本
- 结构化系统文献检索(截至2025年),纳入31篇报告男性CHH逆转的文章。
主要发现
- 约10%男性CHH患者停激素治疗后出现逆转,伴HPG轴持续激活和/或生育力。
- 逆转普遍发生在激素治疗达到正常血清睾酮水平之后。
- 睾酮替代治疗中睾丸增大是HPG轴激活的标志,但逆转不总是持久。
- 逆转病例呈连续谱,从严重GnRH缺乏的嗅觉正常个体到部分自发青春期的较轻病例(Pasqualini综合征亚型)。
关键数值与推荐
- 约10%男性CHH患者发生逆转。
- GNRHR致病变异促进逆转,ANOS1变异几乎排除HPG轴恢复。
- 嗅觉表型(如嗅觉缺失)不预测HPG轴恢复。
临床怎么用
- 对男性CHH患者,结合临床体征和基因检测识别逆转可能者。
- 对潜在逆转患者进行密切监测。
- 激素治疗达到正常睾酮水平后关注睾丸增大等HPG轴激活标志。
局限性
- 逆转的精确机制尚未阐明。
- 逆转不总是持久。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Congenital genetic disorders have been traditionally considered to be lifelong. An exception to this long-held view is the reversal of congenital hypogonadotropic hypogonadism (CHH). Approximately 10% of male individuals with CHH undergo reversal with sustained hypothalamic-pituitary-gonadal (HPG) axis activation and/or fertility after discontinuing hormonal treatment. EVIDENCE ACQUISITION: We conducted a structured, systematic literature search to identify relevant articles published on reversal of CHH in males (up to 2025). This mini-review provides a concise overview and synthesizes findings to inform clinical management of CHH. EVIDENCE SYNTHESIS: We identified 31 articles reporting reversal of CHH in males, including cases of severe GnRH deficiency and individuals harboring pathogenic variants in CHH genes. Reversal is distinct from delayed puberty, and olfactory phenotype (ie, anosmia) does not predict HPG axis recovery. In males, reversal universally occurs after achieving normal serum testosterone levels on hormone therapy. Testicular growth on testosterone replacement is a hallmark of HPG axis activation-yet reversal is not always lasting. Cases exist on a continuum from normosmic individuals with severe GnRH deficiency to milder cases with partial spontaneous puberty (Pasqualini syndrome subtype). Pathogenic variants in GNRHR favor reversal while ANOS1 variants virtually exclude HPG axis recovery. CONCLUSION: The reversal phenomenon in males has expanded our understanding of the regulation of human reproduction-yet precise mechanism(s) have yet to be elucidated. Clinicians can use clinical signs and genetic testing to identify patients who may benefit from close surveillance of reversal. Insights from reversal of CHH reversal have helped shape the first tailored approach managing CHH.
引用
- Dwyer AA, Stamou M. Reversal of Congenital Hypogonadotropic Hypogonadism. J Clin Endocrinol Metab. 2026. PMID: 41206002. doi:10.1210/clinem/dgaf610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。